Evidence method
Level · gp.fundamentals.debt_to_revenue
29.07% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
WST · Mar 31, 2023
WEST PHARMACEUTICAL SERVICES INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000105770-23-000023General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
11.46% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
19.27% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-0.47% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
62.38% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
37.86% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
21.67% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.39% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
1.19% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History39 statesSelf-history eligible
Mar 31, 201910/10 normalizedLevel 3Jun 30, 201910/10 normalizedLevel 3Sep 30, 201910/10 normalizedLevel 3Dec 31, 20198/8 normalizedLevel 3Mar 31, 20209/9 normalizedLevel 3Jun 30, 20209/9 normalizedLevel 3Sep 30, 20209/9 normalizedLevel 3Dec 31, 20209/9 normalizedLevel 3Mar 31, 20219/9 normalizedLevel 3Jun 30, 20219/9 normalizedLevel 3Sep 30, 20219/9 normalizedLevel 3Dec 31, 20219/9 normalizedLevel 3Mar 31, 20229/9 normalizedLevel 3Jun 30, 20229/9 normalizedLevel 3Sep 30, 20229/9 normalizedLevel 3Dec 31, 20229/9 normalizedLevel 3Mar 31, 20239/9 normalizedLevel 3Jun 30, 20239/9 normalizedLevel 3Sep 30, 20239/9 normalizedLevel 3Sep 30, 20269/9 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 7.24%
- Current
- 29.07%
- Delta
- 21.83%
- Previous
- 9.86%
- Current
- 11.46%
- Delta
- 1.60%
- Previous
- 25.08%
- Current
- 19.27%
- Delta
- -5.81%
- Previous
- 1.95%
- Current
- -0.47%
- Delta
- -2.43%
- Previous
- 14.37%
- Current
- 62.38%
- Delta
- 48.01%
- Previous
- 39.36%
- Current
- 37.86%
- Delta
- -1.50%
- Previous
- 25.43%
- Current
- 21.67%
- Delta
- -3.75%
- Previous
- 2.03%
- Current
- 2.39%
- Delta
- 0.36%
- Previous
- 0.82%
- Current
- 1.19%
- Delta
- 0.37%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · WST Fundamental State →Has State · WEST PHARMACEUTICAL SERVICES INC →Transitioned To · WST Fundamental State →Transitioned To · WST BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · WST CAPEX_INTENSITY_INCREASED →Transitioned To · WST CASH_GENERATION_DECREASED →Transitioned To · WST GROWTH_DECREASED →Transitioned To · WST INVENTORY_PRESSURE_INCREASED →Transitioned To · WST MARGIN_DECREASED →Transitioned To · WST PROFITABILITY_DECREASED →Transitioned To · WST R_AND_D_INTENSITY_INCREASED →Transitioned To · WST SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.